China Pharma Holdings (CPHI) Current Leases (2019 - 2026)

China Pharma Holdings (CPHI) has reported Current Leases for 8 consecutive years, with $73069.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Leases changed N/A year-over-year to $73069.0; the trailing twelve-month figure through Jun 2026 stood at $73069.0 (changed N/A YoY), and the FY2025 full-year result was $71628.0, up 82.15% from the prior year.
• Current Leases advanced to $73069.0 in Q2 2026 per CPHI's latest filing, from $71386.0 in the prior quarter.
• Across five years, Current Leases topped out at $86672.0 in Q1 2022 and bottomed at $19776.0 in Q1 2025.
• Historically, Current Leases has averaged $63593.8 across 5 years, with a median of $71628.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Current Leases tumbled 76.21% in 2023, then surged 279.71% in 2024.
• Over 5 years, Current Leases stood at $40445.0 in 2022, then soared by 92.18% to $77727.0 in 2023, then slumped by 49.41% to $39323.0 in 2024, then soared by 82.15% to $71628.0 in 2025, then climbed by 2.01% to $73069.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $73069.0, $71386.0, and $71628.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.